C Grassi

Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment

S. De Flora, C Grassi, L. Carati · European Respiratory Journal · 1997 · 195 citations · Full text

Reference Values of Maximal Respiratory Mouth Pressures: A Population-based Study

Claudio Bruschi, Isa Cerveri, Maria C. Zoia et al. · American Review of Respiratory Disease · 1992 · 185 citations

Asthma, Physical Activity, Anthropometric Indicator +16

MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial

Maurizio Luisetti, C Sturani, David M. Sella et al. · European Respiratory Journal · 1996 · 94 citations · Full text

Antifibrotic Therapy, Inflammatory Lung Disease, Advanced Lung Disease +9

Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin

H. Lode, Javier Garau, C Grassi et al. · European Respiratory Journal · 1995 · 86 citations · Full text

Community-acquired Pneumonia, Anti-infective Agents, Antimicrobial Susceptibility +14

Ceftazidime Monotherapy vs. Ceftriaxone/Tobramycin for Serious Hospital-Acquired Gram-Negative Infections

Eric Rubinstein, H. Lode, C Grassi · Clinical Infectious Diseases · 1995 · 85 citations

Fatal Prognosis, Randomized Clinical Trial, Health Sciences +10